SCHEMBL5175233

SCHEMBL5175233

CCCOC(C)Cc1ccccc1Oc1ncccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
KMT2A Q03164 7/20 0.45
MEN1 O00255 6/20 0.45
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
ATM Q13315 1/20 0.45
LTA4H P09960 1/20 0.43
MAPT P10636 4/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RECQL P46063 1/20 0.40
GFER P55789 1/20 0.40
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 2/20 0.39
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175478 0.81 CYP1A2 (0.38) ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL5175228 0.76 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL3151065 0.75 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL31701918 0.74 ALDH1A1 (0.60) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL11033001 0.72 ALDH1A1 (0.80) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL1340893 0.72 ALDH1A1 (0.80) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL18613017 0.71 ALDH1A1 (0.78) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL3158662 0.71 ALDH1A1 (0.78) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL10522426 0.71 ALDH1A1 (0.77) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL23343548 0.70 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751113-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS Bristol-Myers Squibb Pharma Company (US) 2007-02-14 EP disclosed
WO-2005113511-A9 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL MYERS SQUIBB CO (US) 2006-02-02 WO disclosed
WO-2005113511-A1 UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-01 WO disclosed